$AGEN
Agenus Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Lexington, MA
AGEN chart
What traders are saying about $AGEN
Latest postsAgenus Inc news
- B. Riley Securities maintains Agenus at Buy, raises price target to $16 from $14
TradingView ·
- Agenus Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
Simply Wall St ·
- Agenus Reports Long-Term Survival Outcomes of BOT+BAL in Refractory MSS Colorectal Cancer at SITC 2026
Oncodaily ·
- Agenus Inc. (AGEN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer
Oncodaily ·
- Agenus Reports Third Quarter 2026 Financial Results, Highlighting BOT+BAL Clinical Development Progress
Oncodaily ·
- Agenus' Q3 Earnings Match Estimates, Revenues Miss Mark, Stock Down
Yahoo Finance ·
- Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026
Yahoo Finance ·
- Agenus (NasdaqCM:AGEN) Stock Forecast & Analyst Predictions
Simply Wall St ·
- Agenus (AGEN) Q3 Earnings Meet Estimates
Yahoo Finance ·
- Agenus: Q3 Earnings Snapshot
Yahoo Finance ·
- Agenus 3Q 2026: Revenue $31.49M, EPS $0.02 — 10-Q Summary
TradingView ·
Agenus Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $114.2M | $103.5M | $156.3M | $98.0M |
| Net income | -$3.1M | -$232.3M | -$257.4M | – |
| Diluted EPS | $0.00 | $-10.59 | $-13.75 | $-15.64 |
| Total assets (year end) | $226.8M | $226.3M | $313.9M | $413.6M |
| Cash and equivalents (year end) | $3.0M | $40.4M | $76.1M | $178.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Agenus Inc
- Ticker
- AGEN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1098972
- Former names
- ANTIGENICS INC /DE/
Frequently asked questions
What exchange is Agenus Inc listed on?
Agenus Inc trades on the Nasdaq under the ticker symbol AGEN.
What industry is Agenus Inc in?
Agenus Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Agenus Inc headquartered?
Agenus Inc's business address on file with the SEC is in Lexington, MA.
When does Agenus Inc's fiscal year end?
Agenus Inc's fiscal year ends on December 31.
How much revenue did Agenus Inc report?
Agenus Inc reported $114.2M in revenue for calendar year 2025, according to its SEC filings.